IN188098B - - Google Patents

Info

Publication number
IN188098B
IN188098B IN203MU2000A IN188098B IN 188098 B IN188098 B IN 188098B IN 203MU2000 A IN203MU2000 A IN 203MU2000A IN 188098 B IN188098 B IN 188098B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Ashok Vasudev Anvekar
Jayant S Joshi
Subhash Vinayak Kapre
Original Assignee
Serum Inst India Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serum Inst India Ltd filed Critical Serum Inst India Ltd
Priority to IN203MU2000 priority Critical patent/IN188098B/en
Publication of IN188098B publication Critical patent/IN188098B/en

Links

IN203MU2000 2000-03-09 2000-03-09 IN188098B (enrdf_load_stackoverflow)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN203MU2000 IN188098B (enrdf_load_stackoverflow) 2000-03-09 2000-03-09

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN203MU2000 IN188098B (enrdf_load_stackoverflow) 2000-03-09 2000-03-09

Publications (1)

Publication Number Publication Date
IN188098B true IN188098B (enrdf_load_stackoverflow) 2002-08-17

Family

ID=29727206

Family Applications (1)

Application Number Title Priority Date Filing Date
IN203MU2000 IN188098B (enrdf_load_stackoverflow) 2000-03-09 2000-03-09

Country Status (1)

Country Link
IN (1) IN188098B (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2549690R1 (es) * 2012-10-18 2016-01-11 Inosan Biopharma, S.A. Inmunoterapéuticos polivalentes de alta especificidad basados en anticuerpos modificados y formulación liofilizada inyectable altamente segura y eficaz

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2549690R1 (es) * 2012-10-18 2016-01-11 Inosan Biopharma, S.A. Inmunoterapéuticos polivalentes de alta especificidad basados en anticuerpos modificados y formulación liofilizada inyectable altamente segura y eficaz
US10538577B2 (en) 2012-10-18 2020-01-21 Inosan Biopharma S.A. Polyvalent immunotherapeutics

Similar Documents

Publication Publication Date Title
BE2017C009I2 (enrdf_load_stackoverflow)
BE2014C035I2 (enrdf_load_stackoverflow)
BE2014C009I2 (enrdf_load_stackoverflow)
JP2003531414A5 (enrdf_load_stackoverflow)
JP2003523559A5 (enrdf_load_stackoverflow)
JP2002196382A5 (enrdf_load_stackoverflow)
JP2001077739A5 (enrdf_load_stackoverflow)
JP2002540474A5 (enrdf_load_stackoverflow)
JP2000293204A5 (enrdf_load_stackoverflow)
JP2001216799A5 (enrdf_load_stackoverflow)
JP2002152639A5 (enrdf_load_stackoverflow)
JP2003502841A5 (enrdf_load_stackoverflow)
JP2003508852A5 (enrdf_load_stackoverflow)
JP2002001975A5 (enrdf_load_stackoverflow)
JP2002131137A5 (enrdf_load_stackoverflow)
IN192481B (enrdf_load_stackoverflow)
IN188098B (enrdf_load_stackoverflow)
JP2001281769A5 (enrdf_load_stackoverflow)
BR122012015772A2 (enrdf_load_stackoverflow)
CN3146291S (enrdf_load_stackoverflow)
CN3141437S (enrdf_load_stackoverflow)
CN3149762S (enrdf_load_stackoverflow)
CN3148468S (enrdf_load_stackoverflow)
CN3146861S (enrdf_load_stackoverflow)
CN3142478S (enrdf_load_stackoverflow)